Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Tat-NR2B9c

Base Information
  • Chemical Name:Tat-NR2B9c
  • CAS No.:500992-11-0
  • Molecular Formula:C105H188N42O30
  • Molecular Weight:2518.9
  • Hs Code.:
  • NCI Thesaurus Code:C170212
  • ChEMBL ID:CHEMBL502630
  • Mol file:500992-11-0.mol
Tat-NR2B9c

Synonyms:Tat-NR2B9c

Suppliers and Price of Tat-NR2B9c
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • DC Chemicals
  • Tat-NR2B9c >98%
  • 100mg
  • $ 600.00
  • ChemScene
  • Tat-NR2B9c
  • 10mg
  • $ 336.00
  • ChemScene
  • Tat-NR2B9c
  • 5mg
  • $ 216.00
  • ChemScene
  • Tat-NR2B9c
  • 1mg
  • $ 84.00
  • ChemScene
  • Tat-NR2B9c
  • 25mg
  • $ 660.00
  • Biorbyt Ltd
  • Tat-NR2B9c
  • 25 mg
  • $ 674.90
  • Biorbyt Ltd
  • Tat-NR2B9c
  • 10 mg
  • $ 460.70
  • Biorbyt Ltd
  • Tat-NR2B9c
  • 5 mg
  • $ 382.50
Total 10 raw suppliers
Chemical Property of Tat-NR2B9c
Chemical Property:
  • XLogP3:-19.3
  • Hydrogen Bond Donor Count:49
  • Hydrogen Bond Acceptor Count:40
  • Rotatable Bond Count:99
  • Exact Mass:2518.4510076
  • Heavy Atom Count:177
  • Complexity:5380
Purity/Quality:

97% *data from raw suppliers

Tat-NR2B9c >98% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)N
  • Isomeric SMILES:CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)N
  • Recent ClinicalTrials:Field Randomization of Nerinetide (NA-1) Therapy in Early Responders
  • Recent EU Clinical Trials:A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 500992-11-0